https://pharmaregnews.com/2021/04/15/cyclicas-drug-discovery-platform-suggests-capmatinib-demonstrates-robust-antiviral-effects-in-covid-19-models/
Cyclica’s drug discovery platform suggests CAPMATINIB demonstrates robust antiviral effects in COVID-19 models